Bayer Aktienges Ads (BAYRY) 106.9300 $BAYRY Jacobs

New Post Public Reply Private Reply Replies (0) Message Board

Aug 31, 2016 at 7:07 PM

Bayer Aktienges Ads (BAYRY) 106.9300 $BAYRY

Jacobs Acquires BAYQIK(R) Sulfuric Acid Converter Technology from Bayer AG
BusinessWire - Wed Aug 31, 6:45AM CDT
Jacobs Engineering Group Inc. (NYSE:JEC) announced today it acquired the patent rights for BAYQIK(R) quasi-isothermal sulfuric acid converter technology and other related technology from Bayer AG.
JEC: 52.69 (-0.79)

Andreas Fibig to Join Bunge Limited Board of Directors
PR Newswire - Mon Aug 29, 3:01PM CDT
Bunge Limited (NYSE: BG) today announced that Andreas Fibig has been appointed to its Board of Directors, effective immediately.
IFF: 138.58 (+0.13), BG: 63.90 (+1.38)

SECFilings.com: Bayer's ClariSpray Success Bodes Well for Innovus Pharmaceuticals' FlutiCare
Marketwire Canada - Thu Aug 25, 5:00AM CDT
REDONDO BEACH, CA--(Marketwired - Aug 25, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, recently published an article highlighting the potential FDA approval of Innovus Pharmaceuticals' (OTCQB: INNV) FlutiCare™ in the nasal allergy market following the recent approval of Bayer AG's ClariSpray™.

Company News for August 24, 2016
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:59AM CDT
Companies in The News are: SJM,MBLY,DLPH,BAYRY,MON,DAKT
DAKT: 9.53 (-0.12), MON: 106.50 (-0.94), MBLY: 48.89 (+0.71), DLPH: 70.66 (+0.25), SJM: 141.79 (+2.03)

Zwerling, Schachter & Zwerling, LLP Announce the Partial Settlement of a Class Action Lawsuit Involving the Antibiotic Drug Cipro
PR Newswire - Mon Aug 22, 5:05PM CDT
If You Paid for the Antibiotic Cipro in CaliforniaYou Could Get Money from a Class Action Settlement

Top 3 Research Reports for August 15, 2016
Sheraz Mian - Zacks Investment Research - Mon Aug 15, 1:44PM CDT
Top 3 Research Reports for August 15, 2016
BIIB: 305.63 (-2.23), EXC: 34.00 (+0.19), AZN: 32.81 (-0.40), APA: 49.70 (-2.73), CAT: 81.95 (-0.53)

California State Court Green-Lights Essure Product Liability Suits Against Bayer Following Argument by Grant & Eisenhofer and Co-Counsel
PR Newswire - Fri Aug 05, 6:32PM CDT
A California state court has given a green light to a series of product liability lawsuits brought against Bayer Corporation and several of its subsidiaries by 14 women who alleged that they sustained injuries from Bayer's permanent birth control device Essure.

Regeneron (REGN) Tops Q2 Earnings, Keeps '16 Eylea View
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 10:33AM CDT
Regeneron Pharmaceuticals (REGN) reported better-than-expected second-quarter 2016 earnings of $2.10 per share.
ANIP: 59.74 (-1.12), SNY: 38.47 (-0.31), REGN: 392.55 (-2.67)

Will ImmunoGen (IMGN) Disappoint Again on Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 5:30PM CDT
ImmunoGen (IMGN), which is set to report its fourth-quarter fiscal 2016 results on Aug 4, had recorded a negative surprise of 23.33% last quarter.
BMRN: 93.89 (-1.06), IMGN: 2.81 (-0.07)

Regeneron (REGN) Q2 Earnings: Can the Stock Surprise?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 10:58AM CDT
Regeneron Pharmaceuticals (REGN), which is set to release second-quarter 2016 results on Aug 4, had recorded an average negative earnings surprise of 0.06% last quarter.
CNAT: 1.81 (-0.07), SNY: 38.47 (-0.31), REGN: 392.55 (-2.67)

Bayer (BAYRY) Beats on Q2 Earnings, Updates 2016 Outlook
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:10AM CDT
Bayer's (BAYRY) second-quarter 2016 core earnings of $2.34 per share topped estimates while revenues marginally missed expectations; it revised its 2016 outlook.
MON: 106.50 (-0.94), INVA: 11.09 (+0.08), ANIP: 59.74 (-1.12)

CRISPR Therapeutics Raises Additional $38M as Part of Series B Financing
BusinessWire - Fri Jun 24, 6:00AM CDT
CRISPR Therapeutics, a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into transformative medicines, today announced an additional $38 million closing of its Series B financing. This additional investment brings the total Series B financing round to nearly $140 million. The previous Series B investment was led by Vertex Pharmaceuticals and Bayer Global Investments, an affiliate of Bayer AG, as part of the company's strategic investment in CRISPR Therapeutics. This second, oversubscribed closing of the Series B financing, includes several new institutional investors and specialized healthcare funds. Participating investors in this round include Franklin Templeton Investments, New Leaf Venture Partners, funds advised by Clough Capital Partners L.P. and Wellington Capital Management L.L.P., and other undisclosed funds specializing in life sciences.

Paratek Reports Positive Phase III Data on Antibiotic Drug
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 10:03AM CDT
Paratek Pharmaceuticals (PRTK) announced positive phase III results on omadacycline for the treatment of acute bacterial skin and skin structure infections.
AGN: 234.54 (-2.45), PFE: 34.80 (-0.08), PRTK: 13.47 (+0.11)

Philip Blake of Bayer Recognized in STEMconnector's® 100 CEO Leaders in STEM
PR Newswire - Thu Jun 16, 11:49AM CDT
Philip Blake, President of Bayer Corporation and Head of the Americas Region for Pharmaceuticals, has been recognized in STEMconnector's® 100 CEO Leaders in STEM publication.

Stock Market News for June 01, 2016
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 9:10AM CDT
Benchmarks ended mostly in the red on Tuesday following a cautious stance among investors ahead of the release of major economic reports this week
KO: 43.43 (+0.19), MON: 106.50 (-0.94), EA: 81.23 (-0.50), PFE: 34.80 (-0.08), SYY: 51.86 (-0.07), STZ: 164.05 (-2.10), XOM: 87.14 (-0.38), PEP: 106.75 (-0.46), NVDA: 61.34 (-0.29), DD: 69.60 (-0.64), PG: 87.31 (-0.23), CVX: 100.58 (-1.12), DOW: 53.64 (-0.35), PPG: 105.88 (-1.40), ECL: 123.05 (-0.93)

Stock Market News for May 31, 2016
Zacks Equity Research - Zacks Investment Research - Tue May 31, 9:10AM CDT
Benchmarks finished in the green on Friday after Fed Chairwoman Janet Yellen said a rate rise might be appropriate in coming months
DLTR: 82.70 (-1.41), GS: 169.46 (+0.09), MON: 106.50 (-0.94), JPM: 67.50 (unch), C: 47.74 (-0.16), WFC: 50.80 (+0.18), BAC: 16.14 (-0.05), ULTA: 247.21 (+2.24), TOL: 31.09 (-0.16), BHI: 49.13 (-0.87)

Monsanto rejects $62B Bayer bid, but still open to talks
AP - Tue May 24, 5:10PM CDT
NEW YORK (AP) — Monsanto rejected Bayer's $62 billion takeover bid, calling it "incomplete and financially inadequate."
MON: 106.50 (-0.94)

ETFs to Watch on Monsanto Buyout Offer
Sweta Killa - Zacks Investment Research - Tue May 24, 8:46AM CDT
The German chemical giant made all-cash bid to acquire Monsanto for $62 billion, including debt, putting these ETFs on spotlight.
XLB: 48.56 (-0.49), SYT: 87.25 (+0.18), MON: 106.50 (-0.94), MOO: 50.94 (+0.02), VEGI: 24.27 (+0.06), IYM: 79.99 (-0.75), DD: 69.60 (-0.64), DOW: 53.64 (-0.35)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JennAir and Cosentino Introduce Seamless Kitchen Aesthetics

It's not every day that the kitchen landscape gets a bold makeover, but JennAir and Cosentino seem to think it's time. Introducing their latest splash, the JennAir x Dekton panel collection is here to redefine what luxury kitchens can look like—an embodiment of seamless beauty that’s more sculpture than cooking space. Elevating Kitchen Design So, what's the buzz about...

Roof Replacement Timelines: Key Insights for PA Homeowners

There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...

University of Phoenix Grads Shine in Job Readiness

University of Phoenix Graduates Proving Their Worth Dive straight into the world of University of Phoenix grads, and you're looking at some folks who seem to have the workplace game figured out. A fresh Harris Poll, done on behalf of the University itself, paints a rosy picture of these graduates from the eyes of those who actually supervise them. Turns out, managers are...

Vortex Expands UK Reach with Torrent Acquisition Boost

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

Crucial Insights for South GA Home Insurance Choices

Understanding the Insurance Jargon Here we go again, dealing with insurance gobbledygook that’s about as clear as mud to most of us. Homeowners in South Georgia are being urged to pay attention to the differences between replacement cost and actual cash value in their insurance policies. This ain't just legalese, folks—it's your protection when disaster strikes in our...

OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

EPR Fireworks, Schedule2.IT Enhance EMS Integration

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

Medicare Payment Proposal Faces Doctor Backlash in D.C.

Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...

Reel Wheels: Hollywood's Iconic Car Collection Unveiled

Rolling Out the Legends: A Peek Inside Reel Wheels Picture something that screams Hollywood. Now, give it wheels, maybe some wings too. That's what Reel Wheels Entertainment has laid out—a mind-boggling assortment of film and TV vehicles. Released on September 30, 2026, this collection is a treasure trove of Hollywood's on-screen memorabilia, and they're not just...

Local Expertise in Real Estate: Key to Success?

Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...